Group One Trading’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
Other funds holding NBSE
GC
ACM
DCMIC
CMU
SCM
PAMP
JAMONY
CM
Group One Trading's NBSE Position: Q1 2021 in Review
Group One Trading sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q1 2021, closing a stake of 193 shares — an estimated $35K sold.
Group One Trading first reported a position in NBSE in Q1 2014 and held it in 15 quarters. The position peaked at $322K in Q1 2014. 56 funds tracked by Wall St. Rank hold NBSE as of Q1 2021.
- Group One Trading reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
- Group One Trading sold 193 NeuBase Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $35K.
- Group One Trading first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q1 2014 and held it in 15 quarters.
- Group One Trading's NeuBase Therapeutics, Inc. Common Stock position peaked at $322K in Q1 2014.
- 56 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q1 2021.
Based on Group One Trading's 13F filing for Q1 2021, filed 12 May 2021.